Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 3 February, we hosted a visiting group of students from Buckinghamshire College.

The students are taking a science course that asks them to spend some time specifically looking at the management of health and safety.

All hazards need a justification, so we began our visit talking about the cancer and the science. There is still a pressing need for better cancer treatments and our work fits into that global effort.

Hazards and risks are managed by a hierarchy of controls.  We use engineering controls to prevent harms happening; policy and training to make sure our scientists know how to handle and manage hazards, and personal protective equipment to offer a last line of protection.

The students spent time using their knowledge of our work to predict what hazards we face and how we control them. They then took a lab tour and saw how this works in practice.

A very rewarding group; we wish them well with their studies.

Similar stories

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

Festive Science Image Competition Winners

Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.

The Howat Foundation to fund Chair in Clinical Oncology

Oxford Cancer announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation

Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment

New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.